Stereoselective kinetics of warfarin binding to human serum albumin: Effect of an allosteric interaction
Authors:
Abstract
Kinetic and equilibrium binding studies were performed on the interaction of warfarin enantiomers with human serum albumin (HSA) in the absence and presence of lorazepam acetate (LoAc) enantiomers. Binding kinetics were followed by recording changes in the fluorescence of warfarin upon binding to HSA using the stopped‐flow technique. The binding of (R)‐warfarin displayed an exponentially increasing fluorescence, satisfying the two‐step mechanism reported previously for the racemate, i.e., a diffusion controlled pre‐equilibrium is followed by a slower rearrangement of the complex. In the case of (S)‐warfarin, the signal was biphasic: a fast fluorescence enhancement was followed by a slow decline. The different kinetic features indicate that the equilibrium conformations of the [(S)‐warfarin‐HSA] and [(R)‐warfarin‐HSA] complexes are achieved via different mechanisms. The phenomenon was seen in buffers of different pH and compositions. Equilibrium binding measurements indicated significantly lower molar intrinsic fluorescence for the (S)‐warfarin complex, suggesting differences in the microenvironments of the bound enantiomers. In the presence of (S)‐LoAc, the allosterically enhanced binding of (S)‐warfarin manifested itself in accelerated relaxation kinetics. In accordance with the low molar intrinsic fluorescence determined for the stable ternary complex, the amplitude of the decline in fluorescence became larger. Chirality 14:442–448, 2002.Keywords
This publication has 24 references indexed in Scilit:
- Crystal Structure Analysis of Warfarin Binding to Human Serum AlbuminJournal of Biological Chemistry, 2001
- Five recombinant fragments of human serum albumin—tools for the characterization of the warfarin binding siteProtein Science, 2000
- Site I on human albumin: Differences in the binding of (R)- and (S)-warfarinChirality, 1999
- Protein-Binding High-Performance Frontal Analysis of (R)- and (S)-warfarin on HSA with and without PhenylbutazoneJournal of Pharmaceutical Sciences, 1997
- Characterization of site I on human serum albumin: concept about the structure of a drug binding siteBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996
- Chiral Separation Mechanisms in Protein-Based HPLC Columns. 1. Thermodynamic Studies of (R)- and (S)-Warfarin Binding to Immobilized Human Serum AlbuminAnalytical Chemistry, 1994
- Atomic structure and chemistry of human serum albuminNature, 1992
- Use of a Human Serum Albumin-Based High-Performance Liquid Chromatography Chiral Stationary Phase for the Investigation of Protein Binding: Detection of the Allosteric Interaction between Warfarin and Benzodiazepine Binding SitesJournal of Pharmaceutical Sciences, 1991
- Binding of Nonsteroidal Anti-Inflammatory Agents and Their Effect on Binding of Racemic Warfarin and Its Enantiomers to Human Serum AlbuminJournal of Pharmaceutical Sciences, 1989
- Stereoselective binding of 3-acetoxy-, and 3-hydroxy-1,4-benzodiazepine-2-ones to human serum albuminBiochemical Pharmacology, 1986